-
Mashup Score: 0
Roche’s Actemra is the first FDA approved monoclonal antibody to be used for COVID-19.
Source: Contagion LiveCategories: Infectious Disease, Latest HeadlinesTweet
-
Mashup Score: 2
Roche’s Actemra is the first FDA approved monoclonal antibody to be used for COVID-19.
Source: Contagion LiveCategories: Infectious Disease, Latest HeadlinesTweet-
#Breaking_news Roche’s #Actemra (#tocilizumab) is the first #FDA approved monoclonal antibody to be used for #COVID19 https://t.co/fPUKcQdV21
-
-
Mashup Score: 1
FDA approved this intravenous tocilizumab (Actemra) for hospitalized adults with COVID-19.
Source: Infection Control TodayCategories: Infectious Disease, Latest HeadlinesTweet-
FDA approved this intravenous tocilizumab (Actemra) for hospitalized adults with COVID-19. https://t.co/LhTrRIh41a #covid19 #Tocilizumab @US_FDA #pandemic
-
-
Mashup Score: 0FDA accepts abbreviated BLA for Biogen’s tocilizumab biosimilar - 1 year(s) ago
The FDA has accepted an abbreviated biologics license application for a tocilizumab biosimilar candidate, according to a press release from Biogen. “The FDA filing is supported by phase 3 data from a comparative clinical trial demonstrating equivalent efficacy and a comparable safety and immunogenicity profile to the reference product,” Ian Henshaw, the head of global biosimilars at
Source: www.healio.comCategories: Latest Headlines, RheumatologyTweet-
The FDA has accepted an abbreviated biologics license application for a #tocilizumab #biosimilar candidate #MedTwitter #RheumTwitter https://t.co/Gc8ADT1jUo
-
-
Mashup Score: 0
Objectives Tocilizumab showed trends for improving skin fibrosis and prevented progression of lung fibrosis in systemic sclerosis (SSc) in randomised controlled clinical trials. We aimed to assess safety and effectiveness of tocilizumab in a real-life setting using the European Scleroderma Trial and Research (EUSTAR) database. Methods Patients with SSc fulfilling the American College of…
Source: RMD OpenCategories: Latest Headlines, RheumatologyTweet-
Effectiveness of #tocilizumab in #systemic #sclerosis: @EUSTAR_org cohort results ▶️ no effect on primary or secondary endpoints ▶️ safety profile ▶️ tocilizumab favoured in all endpoints: potential effect in broader SSc? 🔗 https://t.co/caLpSKwMsh https://t.co/J9nqgRdJiM
-
-
Mashup Score: 1Tocilizumab and Disease Activity in Patients With Polymyalgia Rheumatica Receiving Glucocorticoid Therapy - 2 year(s) ago
This randomized clinical trial compares the effect of intravenous infusions of tocilizumab vs placebo on patients with polymyalgia rheumatica who were receiving glucocorticoid therapy.
Source: jamanetwork.comCategories: Latest Headlines, RheumatologyTweet-
In active #PolyMyalgiaRheumatica on #glucocorticoid, addition of #tocilizumab leads to ✅Improved disease activity ✅Reduced #prednisolone dosage 👉🏽https://t.co/W9pns2LUNO via @JAMANetwork #PMR #prednisone https://t.co/voRF7cMGmp
-
-
Mashup Score: 1
Researchers assessed the effects of tocilizumab among mechanically-ventilated patients hospitalized with COVID-19.
Source: Infectious Disease AdvisorCategories: Infectious Disease, Latest HeadlinesTweet-
Treatment with #tocilizumab was found to significantly decrease the duration of #mechanicalventilation and the risk of #mortality in patients hospitalized with #COVID-19infection https://t.co/tvXR3QjUxM
-
-
Mashup Score: 1
Tocilizumab monotherapy more effective in earlier stages of RA
Source: www.medpagetoday.comCategories: Latest Headlines, RheumatologyTweet-
RT @medpagetoday: What was the study's top-line finding? #Tocilizumab #Rheumatology @ACRheum https://t.co/Xx3BhMNik3 https://t.co/9zxSJ3FUqb
-
-
Mashup Score: 0
Tocilizumab monotherapy more effective in earlier stages of RA
Source: www.medpagetoday.comCategories: General Medicine News, Latest HeadlinesTweet-
What was the study's top-line finding? #Tocilizumab #Rheumatology @ACRheum https://t.co/Xx3BhMNik3 https://t.co/9zxSJ3FUqb
-
-
Mashup Score: 1
AbstractObjectives. The aim of the SIMPACT study was to evaluate the efficacy and safety of MTX-free s.c. tocilizumab (TCZ) therapy in RA patients.Methods. SIMP
Source: OUP AcademicCategories: Latest Headlines, RheumatologyTweet-
Real-world evidence on subcutaneous #tocilizumab in #rheumatoidarthritis ➡️Parallels randomized clinical trials ➡️More effective in biologic-naive patients 👉🏻https://t.co/TLl5qarAfX via @RheumJnl https://t.co/ziB9b2AbUG
-
#ICYMI the #FDA approved the first monoclonal for severe #COVID19 #Roche #tocilizumab https://t.co/fPUKcQdV21